Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 9:01 PM ET

Date/Time Source News Release
05/23/2025 07:00 AM EDT PR Newswire Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities
05/14/2025 04:01 PM EDT PR Newswire Oncolytics Biotech® Reports First Quarter Financial Results and Highlights Clinical Momentum
05/06/2025 07:00 AM EDT PR Newswire Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights
04/24/2025 07:00 AM EDT PR Newswire Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep's Tumor-Fighting Mechanism of Action
04/10/2025 06:09 PM EDT PR Newswire Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital
04/10/2025 07:00 AM EDT PR Newswire Oncolytics Biotech® and Pelareorep Discussed During Recent H.C. Wainwright Key Opinion Leader Event on Oncolytic Immunotherapies in Breast and Pancreatic Cancers
03/08/2025 07:33 AM EST Canada Newswire Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge
03/07/2025 07:00 AM EST PR Newswire Oncolytics Biotech® Reports Highlights and Financial Results for Q4 and Year-End 2024
02/27/2025 10:04 AM EST Canada Newswire Oncology Breakthroughs: How Cancer Research Is Advancing in 2025
02/25/2025 07:00 AM EST Canada Newswire Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
Page

Additional News

As of June 3, 2025 • 9:01 PM ET

Date/Time Source News Release
05/23/2025 09:39 AM EDT Baystreet Investor Attention Turns to Biotech as Traditional Cancer Research Models Strain
05/23/2025 09:13 AM EDT Equity Insider New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs
05/14/2025 07:00 AM EDT Canadian Earnings Reports Expected Canadian Company Earnings on Wednesday, May 14th, 2025
05/14/2025 05:31 AM EDT Canadian Earnings Reports Expected earnings - Oncolytics Biotech Inc.
05/01/2025 10:10 AM EDT Equity Insider New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty
04/14/2025 09:40 AM EDT Equity Insider With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz
03/07/2025 09:21 AM EST Baystreet From Clinical Trials to the Market: Cancer Stocks With Big Potential in 2025
03/07/2025 06:00 AM EST Canadian Earnings Reports Expected Canadian Company Earnings on Friday, March 7th, 2025
03/07/2025 04:31 AM EST Canadian Earnings Reports Expected earnings - Oncolytics Biotech Inc.
02/27/2025 09:58 AM EST Baystreet World Cancer Day Sparks Big Questions About Pollution, Genetics, and Innovation
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.